IPOs With Potential...
Health Care: Health Services
OraSure Technologies Inc. (OSUR: NASDAQ)
$11.00 -0.22 | -1.96%
02/08/12 - 04:00 PM ET
443.70K / 268.70K
Vol / Avg. Vol:11.25 / 11.22
Open / Prev. Close:10.78 - 11.25
Today's Range:6.18 - 11.78
52 Wk Range:20.75%
Performance YTD:TheStreet Rating:
Portfolios with OSUR
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- UserTop Short Squeeze Situations
- Userkeithrez Portfolio 1
- UserBlazed Stocks
- UserBlazeDaily Portfolio 1
- Usereliot74 Portfolio 1
- Userjgandy Portfolio 1
- UserElruin Stock
- UserTo the Stars 2
Latest OSUR Headlines from TheStreet
- OraSure Stock Hits New 52-Week High (OSUR) 02.06.12 | 02:02 pm
- 8 Stocks Ripping Higher on Unusual Volume 01.19.12 | 08:01 pm
- OraSure Reaches New 52-Week High (OSUR) 01.18.12 | 10:01 am
- OraSure Technologies Inc. Stock Upgraded (OSUR) 11.10.11 | 05:11 am
- Hepatitis Testing Company Taking Off
08.24.11 | 06:08 am - OraSure Technologies Inc. Stock Downgraded (OSUR) 08.22.11 | 08:08 am
- OraSure Technologies To Present At The 10th Annual Needham Healthcare Conference 03.28.11 | 09:03 am
- OraSure Technologies Submits CLIA Waiver Application For OraQuick(R) HCV Rapid Test 03.23.11 | 06:03 am
- OraSure Technologies To Present At The Roth 23rd Annual OC Growth Stock Conference 03.04.11 | 04:03 pm
- OraSure Technologies And Roche Announce FDA 510(k) Clearance For Four Fully Automated Oral Fluid Drugs Of Abuse Assays 03.03.11 | 06:03 am
Press Releases for OSUR
Partner Headlines for OSUR
- OraSureTechnologies: A Biotech Company Poised to Revolutionize Two Markets - Seeking Alpha 01.07.11 | 08:01 am
- UPDATE 1-OraSure posts surprise Q3 profit - Reuters 11.09.10 | 05:11 pm
- OraSure Receives HCV Test Approval - Analyst Blog - Zacks 06.28.10 | 10:06 am
- UPDATE 2-OraSure gets FDA nod for hepatitis C test, shares up - Reuters 06.25.10 | 01:06 pm
